Market Research Report

A quick peek into the report

Global Precision Medicine Market

Focus on Ecosystem, Technology, Application, Country Data (21 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030

Some Faq's

Frequently Asked Questions

The global precision medicine market is expected to reach $278.61 billion by the end of 2030. The market is projected to grow at a CAGR of 11.13% during the forecast period, 2020-2030.

Factors driving the growth of the market including advancement of sequencing technologies, rising prevalence of chronic diseases, growing demand for preventive care, and shifting the significance in medicine from reaction to prevention.

Potential opportunities that can boost the growth of the market include targeted gene therapy, expansion into the emerging markets, and collaborations and partnerships across value chain to accelerate the market entry.

The enabling technologies associated with precision medicine include innovators, early adopters, early majority, and late majority.

Some of the key companies operating in the market Abbott Laboratories, Almac Group Ltd, Amgen Inc., ANGLE plc, Astellas Pharma Inc., Astra Zeneca PLC, ASURAGEN INC., Bio-Rad Laboratories, Inc., bioMérieux SA., Bristol-Myers Squibb Company, Cardiff Oncology, CETICS Healthcare Technologies GmbH, Danaher Corporation, Eli Lilly and Company Limited, Epic Sciences, Inc., F. Hoffmann-La Roche Ltd, GE Corporation, and Gilead Sciences, Inc.

Similar Product

You may also like

Global NGS Sample Preparation Market
Published Year: 2019

Global NGS Sample Preparation Market: Focus on Product (Workstation (Open System, Closed System), St

The NGS sample preparation industry analysis by BIS Research projects the market to grow at a...

Global Next-Generation Sequencing Market
Published Year: 2019

Global Next-Generation Sequencing Market: Focus on Products and Services, Applications, Technology,

In 2018, the global next-generation sequencing market was valued at $4.93 billion and is...